Advertisement

Intensive Care Medicine

, Volume 42, Issue 5, pp 942–943 | Cite as

Long-term survival after extracorporeal life support in children with neutropenic sepsis

  • Sile Smith
  • Warwick Butt
  • Derek Best
  • Graeme MacLarenEmail author
Letter

Dear Editor,

Extracorporeal life support (ECLS) is an established intervention for paediatric patients with cardiorespiratory failure failing conventional therapy. Malignancy was historically regarded as a contraindication to ECLS, but analyses of the Extracorporeal Life Support Organization registry demonstrated that ECLS could be appropriate in carefully selected patients [1, 2]. Neutropenic sepsis that complicates chemotherapy has also been regarded as a contraindication to ECLS because of the uncertain long-term prognosis and vulnerability of these children to nosocomial infection. However, there are minimal data on the use of ECLS for this indication. We reviewed our institutional experience of children with febrile neutropenia receiving ECLS.

The study was approved by the institutional review board and waiver of informed consent was granted. A retrospective chart review was conducted on all paediatric patients with known malignancy commenced on ECLS at the Royal Children’s...

Keywords

Hospital Discharge Renal Replacement Therapy Febrile Neutropenia Continuous Renal Replacement Therapy Neutropenic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

References

  1. 1.
    Gow KW, Heiss KF, Wulkan ML et al (2009) Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: the extracorporeal life support experience. Crit Care Med 37:1308–1316CrossRefPubMedGoogle Scholar
  2. 2.
    Di Nardo M, Locatelli F, Palmer K et al (2014) Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experience. Intensive Care Med 40:754–756CrossRefPubMedGoogle Scholar
  3. 3.
    MacLaren G, Butt W, Best D, Donath S, Taylor A (2007) Extracorporeal membrane oxygenation for refractory septic shock in children: one institution’s experience. Pediatr Crit Care Med 8:447–451CrossRefPubMedGoogle Scholar
  4. 4.
    Zinter MS, DuBois SG, Spicer A, Matthay K, Sapru A (2014) Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 40:1536–1544CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Peters MJ, Agbeko RS (2014) Optimism and no longer foolishness? Haematology/oncology and the PICU. Intensive Care Med 40:1589–1591CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2015

Authors and Affiliations

  • Sile Smith
    • 1
  • Warwick Butt
    • 1
    • 2
  • Derek Best
    • 1
  • Graeme MacLaren
    • 1
    • 2
    • 3
    Email author
  1. 1.Paediatric Intensive Care UnitThe Royal Children’s HospitalMelbourneAustralia
  2. 2.Department of PaediatricsThe University of MelbourneParkvilleAustralia
  3. 3.Cardiothoracic Intensive Care UnitNational University Health SystemSingaporeSingapore

Personalised recommendations